AG0034MD

81103-11-9 | Erythromycin, 6-O-methyl-

AG0034MD

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	81103-11-9
Catalog Number	AG0034MD(AGN-PC-0UIQ98)
Chemical Name	Erythromycin, 6-O-methyl-
EC Number	617-200-4
IUPAC Name	(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
InChI	InChI=1S/C38H69NO13/c1-15-26-38(10,45)31(42)21(4)28(40)19(2)17-37(9,47-14)33(52-35-29(41)25(39(11)12)16-20(3)48-35)22(5)30(23(6)34(44)50-26)51-27-18-36(8,46-13)32(43)24(7)49-27/h19-27,29-33,35,41-43,45H,15-18H2,1-14H3/t19-,20-,21+,22+,23-,24+,25+,26-,27+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1
InChI Key	AGOYDEPGAOXOCK-KCBOHYOISA-N
MDL Number	MFCD00865140
Molecular Formula	C38H69NO13
Molecular Weight	747.9534
NSC Number	758704
SMILES	O([C@H]1[C@@](OC)(C)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@](OC)(C)[C@@H](O)[C@H](C)O2)[C@@H]1C)[C@H]3[C@H](O)[C@@H](N(C)C)C[C@@H](C)O3
UNII	H1250JIK0A
Synonyms	6-O-Methylerythromycin, A 56268, A-56268, A56268, Biaxin, Clarithromycin, TE 031, TE-031, TE031, clarithromycin, 81103-11-9, Biaxin, Clarithromycine, Klaricid, 6-O-Methylerythromycin, Clathromycin, 6-O-Methylerythromycin a, Abbott-56268, Macladin, Clarith, Klacid, Kofron, Veclam, Clarithromycinum, Naxy, A-56268, Erythromycin, 6-O-methyl-, Claritromicina, TE-031, Abbotic, Astromen, Bicrolid, Clacine, Clambiotic, Claribid, Claricide, Claridar, Claripen, Fromilid, Heliclar, Klaciped, Mabicrol, Clacee, Clacid, Clarem, Crixan, Cyllid, Klabax, Klarid, Klarin, Maclar, Zeclar, Helas, Mavid, Adel, Biaxin filmtab, Klax, Biaxin HP, Biaxin xl filmtab, Klaricid Pediatric, Vikrol, Clari, Infex, Biaxin XL, DRG-0099, UNII-H1250JIK0A, Clarithromycine [INN-French], Clarithromycinum [INN-Latin], Claritromicina [INN-Spanish], CHEBI:3732, H1250JIK0A, C38H69NO13, CPD000466382, Clarithromycin extended release, Klaricid H.P., (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-12,13-dihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-7-methoxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione, CTY, SMR000466382, SR-05000001992, Clarithromycin (Biaxin, Klacid), clarithromycina, Cyllind, CCRIS 8833, Klaricid XL, HSDB 8055, (14R)-14-Hydroxyclarithromycin, Klaricid H.P, TE031, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy, Clarithromycin,(S), Biaxin (TN), Clarithromycin [USAN:INN:BAN:JAN], Clarithromycin, 97%, Spectrum_000089, Clarithromycin [USAN:USP:INN:BAN:JAN], SpecPlus_000559, 6-O-methyl erythromycin, O(6)-methylerythromycin, 6-O-Methyl-erythromycin, CLA;, Spectrum2_001668, Spectrum3_001667, Spectrum4_000629, Spectrum5_001729, 6-0-methylerythromycin A, AC1L36NJ, CHEMBL1741, SCHEMBL38125, BSPBio_003453, KBioGR_001218, KBioSS_000509, MLS000759516, MLS001201751, MLS001424066, BIDD:GT0200, DivK1c_006655, SPECTRUM1504231, SPBio_001855, Lactoferrin B & Clarithromycin, Lactoferrin H & Clarithromycin, CHEMBL3764720, DTXSID3022829, Clarithromycin & Interleukin-12, CLM & IL-12, KBio1_001599, KBio2_000509, KBio2_003077, KBio2_005645, KBio3_002673, ANX-015, SDP-015, AGOYDEPGAOXOCK-KCBOHYOISA-N, Clarithromycin (JP17/USP/INN), Clarithromycin, >=95% (HPLC), Clarithromycin, >=98% (HPLC), HMS1922H09, HMS2051G18, HMS2090O11, HMS2094M05, HMS2231A08, HMS3715J17, Pharmakon1600-01504231, Clarithromycin suspension or tablets, EBD13493, BDBM50404044, CCG-39086, LMPK04000014, MFCD00865140, NSC758704, s2555, ZINC85534098, C30H54O11.C9H19NO2, AKOS015894242, CS-2576, DB01211, LS-1812, MCULE-7168853332, NC00140, NSC-758704, NCGC00178054-01, 116836-41-0, CC-25899, H781, HY-17508, SAM001246748, SBI-0206716.P001, FT-0602940, C06912, D00276, J10130, AB00053394-10, AB00053394-12, AB00053394-13, AB00053394_14, AB00053394_15, 103C119, C-23486, Q-200870, SR-05000001992-1, SR-05000001992-2, BRD-K49668410-001-07-1, BRD-K49668410-001-18-8, Clarithromycin, European Pharmacopoeia (EP) Reference Standard, Clarithromycin, United States Pharmacopeia (USP) Reference Standard, Clarithromycin Identity, United States Pharmacopeia (USP) Reference Standard, Clarithromycin, Ready Made Solution, 50 mg/mL in DMSO, 0.2 mum filtered, Clarithromycin for peak identification, European Pharmacopoeia (EP) Reference Standard, Clarithromycin, Pharmaceutical Secondary Standard; Certified Reference Material, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-12,13-dihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-12,13-dihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-7-methoxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name), 6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-7-methoxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione, Prevpac, clamicin, Cladribine, 6-Methoxyerythromycin, Eritromicina, 6-O-metil-, CID84029, TE 031, Clarithromycin [USAN:BAN:INN:JAN], C38-H69-N-O13, ACN-037193, CS-O-00499, C2220, A56268, A 56268, D017291, -3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione, CAM, CLA, M 5,

Complexity	1190
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	18
Defined Bond Stereocenter Count	0
Exact Mass	747.477g/mol
Formal Charge	0
Heavy Atom Count	52
Hydrogen Bond Acceptor Count	14
Hydrogen Bond Donor Count	4
Isotope Atom Count	0
Molecular Weight	747.964g/mol
Monoisotopic Mass	747.477g/mol
Rotatable Bond Count	8
Topological Polar Surface Area	183A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	3.2

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302
Packing Group
Precautionary statements	P264-P270-P501-P301+P312+P330-P301+P312a-P330-P501a
UN Code

Certificate of Analysis

Lot Number